Latest regorafenib Stories
Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
Bayer to Present Data on Development Compound BAY 73-4506 at 45th Annual Meeting of the American Society of Clinical Oncology
WAYNE, N.J., May 22 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc.
Word of the Day
- An armed gangster.
The word 'shotta' is an alteration of 'shooter'.